| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLF | Common Stock | Tax liability | $12,833 | -1,548 | -2.7% | $8.29 | 56,447 | 25 Feb 2025 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLF | Stock Appreciation Rights | Award | $0 | +52,445 | $0.000000 | 52,445 | 21 Feb 2025 | Common Stock | 52,445 | $8.31 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022. |
| F2 | Balance includes shares purchased through the Issuer's Employee Stock Purchase Plan since the Reporting Person's last Form 3 filing on June 10, 2024. |
| F3 | Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 21, 2026, February 21, 2027, and February 21, 2028, subject to continued service through such date. |